CymitQuimica logo

CAS 114451-31-9

:

phenelfamycin E

Description:
Phenelfamycin E, with the CAS number 114451-31-9, is a naturally occurring compound belonging to the class of antibiotics known as phenolic compounds. It is derived from certain strains of bacteria, particularly those in the genus Streptomyces. This compound exhibits notable antibacterial properties, making it of interest in pharmaceutical research and development. Phenelfamycin E is characterized by its complex molecular structure, which includes multiple aromatic rings and functional groups that contribute to its biological activity. Its mechanism of action typically involves interference with bacterial cell wall synthesis or protein synthesis, although specific pathways may vary. The compound is also studied for its potential applications in treating various infections, particularly those caused by resistant bacterial strains. Additionally, its stability, solubility, and bioavailability are important factors that influence its efficacy as an antibiotic. Overall, phenelfamycin E represents a significant area of interest in the search for new antimicrobial agents.
Formula:C65H95NO21
InChI:InChI=1/C65H95NO21/c1-13-14-18-29-51-64(7,8)61(72)62(84-53(70)32-43-26-19-17-20-27-43)65(74,87-51)44(63(73)66-31-24-23-25-38(2)58(78-12)39(3)47-33-45(67)46(83-47)28-21-15-16-22-30-52(68)69)37-79-54-35-49(76-10)59(41(5)81-54)86-56-36-50(77-11)60(42(6)82-56)85-55-34-48(75-9)57(71)40(4)80-55/h13-30,39-42,44-51,54-62,67,71-72,74H,31-37H2,1-12H3,(H,66,73)(H,68,69)/b14-13-,16-15+,24-23+,28-21+,29-18+,30-22+,38-25+/t39-,40+,41+,42+,44?,45+,46+,47?,48+,49+,50-,51-,54+,55+,56-,57-,58?,59?,60+,61-,62+,65+/m0/s1
Synonyms:
  • Ganefromycin component (alpha)
  • (2E,4E,6E)-7-((2R*,3R*,5R*)-5-(7-((3E,5E)-3-((O-2,6-Dideoxy-3-O-methyl-alpha-lyxo-hexopyranosyl-(1->4)-O-2,6-dideoxy-3-O-methyl-beta-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-3-O-methyl-alpha-lyxo-hexopyranosyl)oxy)-2-((2S*,3S*,4S*,6R*)-tetrahydro-2,3,4-trihydroxy-5,5-dimethyl-6-((1E,3Z)-1,3-pentadienyl)-2H-pyran-2-yl)propionamido)-2-methoxy-1,3-dimethyl-3,5-heptadienyl)tetrahydro-3-hydroxy-2-furyl)-2,4,6-heptatrienoic acid, 2(sup 3)-phenylacetate
  • (2E,4E,6E)-7-[(2R,3R)-5-{(1S,3E,5E)-7-[(2-{(2R,3R,4R,6S)-2,4-dihydroxy-5,5-dimethyl-6-[(1E,3Z)-penta-1,3-dien-1-yl]-3-[(phenylacetyl)oxy]tetrahydro-2H-pyran-2-yl}-3-{[(2R,4R,6R)-5-{[(2S,4S,5R,6R)-5-{[(2R,4R,5S,6R)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}propanoyl)amino]-2-methoxy-1,3-dimethylhepta-3,5-dien-1-yl}-3-hydroxytetrahydrofuran-2-yl]hepta-2,4,6-trienoic acid (non-preferred name)